{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:36:59Z","timestamp":1787773019281,"version":"build-2784847793"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The coronavirus-19 (COVID-19) pandemic has affected millions of people across the world since early 2020. Besides the large number of case fatalities, this virus has produced significant health-related sequelae involving multiple systems of the body. As with previous coronavirus infections, this was also found to be associated with various neuropsychiatric symptoms. Psychosis has been uncommon, and the few reported cases across the world have forwarded association with either raised inflammatory markers or the consequences of social isolation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This is a retrospective descriptive study of 12 patients, who were admitted with COVID-19 infection and psychosis, between March 2020 and December 2020. Cases of head injury, any neurological or metabolic illnesses, and substance use disorders were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Cases with psychosis formed only 0.19% of all cases of COVID-19 admissions. All of them were young male and employed. Most of them had abrupt onset of psychosis with confusion, delusions, hallucinations, agitation, and sleep disturbances. Investigations including inflammatory markers (C-reactive protein) and computerized tomography scans were largely normal. Medications used were mainly benzodiazepines and antipsychotics. Most of the cases resolved within the second week, and follow-up after a month did not elicit any residual symptoms in majority. Diagnosis was acute and transient psychotic disorder (about 75%), bipolar affective disorder (2 cases), and schizophrenia (one).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The major findings included nonreactive inflammatory markers, quick resolution of symptoms, requirement of low doses of antipsychotic drugs, and no long-term sequelae.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/0972-6748.328784","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T07:08:09Z","timestamp":1681110489000},"page":"S25-S28","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["COVID-19-associated psychosis in Indian settings"],"prefix":"10.4103","volume":"30","author":[{"given":"B. K.","family":"Dutta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. N.","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. V.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sweta","family":"Ratna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/ipj.ipj_64_20","article-title":"Mental health aspects of pandemics with special reference to COVID-19","volume":"29","author":"Srivastava","year":"2020","journal-title":"Ind Psychiatry J"},{"key":"R2-7-20240829","doi-asserted-by":"crossref","first-page":"580","DOI":"10.4103\/mjdrdypu.mjdrdypu_230_20","article-title":"Covid 19 lockdown: Psychological aspects","volume":"13","author":"Chaudhury","year":"2020","journal-title":"Med J DY Patil Vidyapeeth"},{"key":"R3-7-20240829","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.schres.2020.05.005","article-title":"The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research","volume":"222","author":"Brown","year":"2020","journal-title":"Schizophr Res"},{"key":"R4-7-20240829","first-page":"1","article-title":"Neurological and neuropsychiatric complications of COVID-19 in 153 patients : A UK-wide surveillance study","volume":"2","author":"Varatharaj","year":"2020","journal-title":"Lancet"},{"key":"R6-7-20240829","first-page":"59","article-title":"Current status of first rank symptoms","volume":"9","author":"Prasad","year":"1991","journal-title":"NIMHANS J"},{"key":"R7-7-20240829","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jclinepi.2013.08.003","article-title":"The CARE guidelines: Consensus-based clinical case report guideline development","volume":"67","author":"Gagnier","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"R8-7-20240829","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbi.2020.04.027","article-title":"Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms","volume":"87","author":"Troyer","year":"2020","journal-title":"Brain Behav Immun"},{"key":"R9-7-20240829","first-page":"611","article-title":"Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic","volume":"7","author":"Rogers","year":"2020","journal-title":"Lancet"},{"key":"R11-7-20240829","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2147\/PRBM.S264235","article-title":"Available evidence and ongoing hypothesis on corona virus (COVID-19) and psychosis: Is corona virus and psychosis related? A narrative review","volume":"13","author":"Tariku","year":"2020","journal-title":"Psychol Res Behav Manag"},{"key":"R12-7-20240829","doi-asserted-by":"crossref","first-page":"e236940","DOI":"10.1136\/bcr-2020-236940","article-title":"COVID-19-associated brief psychotic disorder","volume":"13","author":"Smith","year":"2020","journal-title":"BMJ Case Rep"},{"key":"R13-7-20240829","doi-asserted-by":"crossref","first-page":"20l02640","DOI":"10.4088\/PCC.20l02640","article-title":"Psychosis in patients in COVID-19-related quarantine: A case series","volume":"22","author":"Finatti","year":"2020","journal-title":"Prim Care Companion CNS Disord"},{"key":"R14-7-20240829","doi-asserted-by":"crossref","first-page":"113097","DOI":"10.1016\/j.psychres.2020.113097","article-title":"New-onset psychosis in COVID-19 pandemic: A case series in Madrid","volume":"290","author":"Rentero","year":"2020","journal-title":"Psychiatry Res"},{"key":"R15-7-20240829","doi-asserted-by":"crossref","first-page":"102406","DOI":"10.1016\/j.ajp.2020.102406","article-title":"Postpartum psychosis in mothers with SARS-CoV-2 infection: A case series from India","volume":"54","author":"Subramanyam","year":"2020","journal-title":"Asian J Psychiatr"},{"key":"R16-7-20240829","doi-asserted-by":"crossref","first-page":"113136","DOI":"10.1016\/j.psychres.2020.113136","article-title":"COVID 19 related psychosis as an interface of fears, socio-cultural issues and vulnerability- case report of two women from India","volume":"290","author":"Chandra","year":"2020","journal-title":"Psychiatry Res"},{"key":"R17-7-20240829","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.psym.2020.06.013","article-title":"Re-examining the association between COVID-19 and psychosis","volume":"61","author":"Ng","year":"2020","journal-title":"Psychosomatics"},{"key":"R18-7-20240829","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1007\/s42399-020-00530-7","article-title":"COVID-19-induced psychosis and suicidal behavior: Case report","volume":"11","author":"Chacko","year":"2020","journal-title":"SN Compr Clin Med"},{"key":"R19-7-20240829","doi-asserted-by":"crossref","first-page":"113254","DOI":"10.1016\/j.psychres.2020.113254","article-title":"Psychotic symptoms in COVID-19 patients. A retrospective descriptive study","volume":"291","author":"Parra","year":"2020","journal-title":"Psychiatry Res"},{"key":"R20-7-20240829","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.psym.2020.05.012","article-title":"COVID-19 psychosis: A potential new neuropsychiatric condition triggered by novel coronavirus infection and the inflammatory response?","volume":"61","author":"Ferrando","year":"2020","journal-title":"Psychosomatics"},{"key":"R21-7-20240829","doi-asserted-by":"crossref","first-page":"100125","DOI":"10.1016\/j.bbih.2020.100125","article-title":"Psychosis in a patient with anti-NMDA-receptor antibodies experiencing significant stress related to COVID-19","volume":"7","author":"Moideen","year":"2020","journal-title":"Brain Behav Immun Health"},{"key":"R22-7-20240829","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/pcn.13107","article-title":"Case with psychotic disorder as a clinical presentation of COVID-19","volume":"74","author":"Majadas","year":"2020","journal-title":"Psychiatry Clin Neurosci"},{"key":"R23-7-20240829","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1192\/bjo.2020.76","article-title":"Persistent psychotic symptoms following COVID-19 infection","volume":"6","author":"Lim","year":"2020","journal-title":"BJPsych Open"},{"key":"R24-7-20240829","doi-asserted-by":"crossref","first-page":"112915","DOI":"10.1016\/j.psychres.2020.112915","article-title":"The emotional impact of Coronavirus 2019-nCoV (new coronavirus disease)","volume":"287","author":"Lima","year":"2020","journal-title":"Psychiatry Res"}],"container-title":["Industrial Psychiatry Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/0972-6748.328784","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:17:02Z","timestamp":1787771822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0972-6748.328784"}},"subtitle":["A retrospective descriptive study"],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":22,"journal-issue":{"issue":"Suppl 1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/0972-6748.328784","relation":{},"ISSN":["0972-6748"],"issn-type":[{"value":"0972-6748","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}